Clinical Trial Update: Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing hepatectomy versus radiofrequency ablation for hepatocellular carcinoma adjacent to major blood vessels has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: COMPLETED